Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy

Journal of Nuclear Medicine

Volumn 43, Issue 7, 2002, Pages 889-895

  Lebtahi, Rachida ^a   Le Cloirec, Joseph ^a   Houzard, Claire ^a   Daou, Doumit ^a   Sobhani, Iradj ^a   Sassolas, Gieneviève ^a   Mignon, Michel ^a   Bourguet, Patrick ^a   Le Guludec, Dominique ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

99mTc P829 scintigraphy; Endocrine tumors; Somatostatin receptor scintigraphy

Indexed keywords

P 829; P829 TECHNETIUM 99M; PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOID; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; INJECTION; ISOTOPE LABELING; LIVER METASTASIS; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR DIAGNOSIS; ZOLLINGER ELLISON SYNDROME;

CARCINOID TUMOR; FEMALE; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; ORGANOTECHNETIUM COMPOUNDS; PEPTIDES, CYCLIC; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; ZOLLINGER-ELLISON SYNDROME;

EID: 0036301683     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hormones producing gastrointestinal tumors contain a high density of somatostatin receptors
2. Distribution of somatostatin receptor in normal and tumour tissue
3. In vivo and in vitro detection of somatostatin receptors in human malignant tissues
4. In vitro detection of somatostatin receptors in human tumors
5. Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2
6. Distribution of somatostatin receptors in normal and neoplastic human tissues: Recent advances and potential relevance
7. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors
8. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
9. Somatostatin receptor imaging in the localization of endocrine tumors
10. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: Consequences with regard to diagnosis, localization, and therapy
11. The role of somatostatin and its analogs in the diagnosis and treatment of tumors
12. The visualization of gastroenteropancreatic tumors
13. 111indium pentetreotide scintigraphy
14. 123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients
15. Somatostatin receptor scintigraphy in carcinoid tumours
16. Indium-111-pentetreotide uptake in endocrine tumors and lymphoma
17. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome
18. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome
19. Localisation of neuroendocrine tumours of the upper gastrointestinal tract
20. Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors
21. Medical oncology considerations in patients with metastatic neuroendocrine carcinomas
22. Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type I
23. Specificity of somatostatin receptor scintigraphy: A prospective study and effects of false-positive localizations on management in patients with gastrinomas
24. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides
25. 99mTc
26. 99mTc-P829
27. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: Safety, efficacy and impact on patient management
28. Somatostatin receptor imaging: Predictive and prognostic considerations
29. Value of somatostatin receptor scintigraphy: A prospective study in gastrinoma of its effect on clinical management
30. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors
31. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours
32. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: Bone scintigraphy compared with somatostatin receptor scintigraphy
33. The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules
34. 99m)Tc depreotide in the evaluation of solitary pulmonary nodules
35. The value of octreotide scintigraphy in patients with lung cancer
36. 111In-DTPA-d-Phe1-octreotide
37. 99mTc-EDDA-HYNIC-Tyr3-octreotide for detection of somatostatin receptor positive tumors and first experience in patients
38. 111In-octreotide
39. 111In-labelled octreotide derivatives